Yahoo News: Doctors see rising rates of colon cancer in younger people
While overall rates of colorectal cancer deaths and diagnoses in the total population are declining, those rates are increasing among young people.
"Cancer is rising in younger patients, and it's disturbing," Rekha Chaudhary, MD, University of Cincinnati Cancer Center physician-researcher and adjunct professor in UC's College of Medicine, said in a recent Ohio Department of Health press conference.
Among those 55 and younger, colorectal cancer rates have been increasing by 1% to 2% a year since about the mid-1990s, and deaths have risen about 1% per year since the mid-2000s, according to the American Cancer Society. Colorectal cancer is the second highest cause of cancer death in the United States.
While research into the cause of this increase is ongoing, experts are focusing on environmental factors, long-term generational changes in diet and the effect of stress.
"The World Health Organization recommends 20-25 grams of fiber a day. The average American gets 15 grams of fiber a day," Chaudhary said. "...It's a lot of fiber, but that is so important for the food for our bacteria, the good bacteria, to decrease the colorectal cancer risks."
Read the Yahoo News story, originally published in the Dayton Daily News.
Featured photo at top of a medical professional holding a colonoscope. Photo/robertprzybysz/iStock.
Related Stories
Local 12, Business Courier highlight Blood Cancer Healing Center
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
Medical News Today: Gene mutation may be a key to lung cancer treatment
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.
Cure: FDA approves tablet form of blood cancer treatment
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.